Ohimachi, Japan

Satoko Fuchizawa


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Innovative Contributions of Satoko Fuchizawa in Medicinal Chemistry**

Introduction

Satoko Fuchizawa, a skilled inventor based in Ohimachi, Japan, has made notable contributions to the field of medicinal chemistry. With a unique focus on propanolamine derivatives, her work is reflective of her dedication to improving health outcomes through innovative solutions.

Latest Patents

Fuchizawa holds a patent for a propanolamine derivative featuring a 1,4-benzodioxane ring. This groundbreaking invention is designed as a medicament that incorporates a novel propanolamine as an active ingredient. The compound, which may exist in a pharmaceutical acceptable salt form, is described by specific structural formulas where R can denote a range of functional groups including hydrogen, halogen, alkyl, or phenyl groups. Its potential applications include serving as a prophylactic or therapeutic agent for conditions such as diabetes, obesity, hyperlipemia, depression, respiratory diseases, and gastrointestinal diseases.

Career Highlights

Throughout her career, Satoko Fuchizawa has been associated with reputable pharmaceutical companies such as Nisshin Pharma Inc. and Kyorin Pharmaceutical Co., Ltd. Her work in these organizations has enabled her to advance her research and development efforts significantly.

Collaborations

In her journey, Fuchizawa has collaborated with esteemed coworkers, including Masahiro Ueno and Koji Kawamura. Their collective expertise has contributed to the refinement and success of her innovative endeavors in the field.

Conclusion

Satoko Fuchizawa exemplifies the impact of dedicated inventors in enhancing medicinal practices through innovation. Her patent for a propanolamine derivative represents a significant stride toward addressing various health challenges, underlining her role as a pivotal figure in contemporary medicinal research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…